These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1704225)

  • 1. N-carboxymethylchitosan-N,O-sulfate as an anti-HIV-1 agent.
    Sosa MA; Fazely F; Koch JA; Vercellotti SV; Ruprecht RM
    Biochem Biophys Res Commun; 1991 Jan; 174(2):489-96. PubMed ID: 1704225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents.
    Buckheit RW; Germany-Decker J; Hollingshead MG; Allen LB; Shannon WM; Janssen PA; Chirigos MA
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1097-106. PubMed ID: 7508723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative kinetic analyses of interaction of inhibitors with Rauscher murine leukemia virus and human immunodeficiency virus reverse transcriptases.
    Cherrington JM; Fuller MD; Mulato AS; Allen SJ; Kunder SC; Ussery MA; Lesnikowski Z; Schinazi RF; Sommadossi JP; Chen MS
    Antimicrob Agents Chemother; 1996 May; 40(5):1270-3. PubMed ID: 8723481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Castanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral activity in vitro and in vivo.
    Ruprecht RM; Bernard LD; Bronson R; Gama Sosa MA; Mullaney S
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):48-55. PubMed ID: 1984055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
    Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
    Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
    Ichimura H; Levy JA
    Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
    Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
    J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-replication by 3'-fluoro-modified nucleosides with low cytotoxicity.
    Matthes E; Lehmann C; von Janta-Lipinski M; Scholz D
    Biochem Biophys Res Commun; 1989 Nov; 165(1):488-95. PubMed ID: 2480126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase.
    Moore PS; Jones CJ; Mahmood N; Evans IG; Goff M; Cooper R; Hay AJ
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):129-34. PubMed ID: 7536411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction.
    Bader JP; McMahon JB; Schultz RJ; Narayanan VL; Pierce JB; Harrison WA; Weislow OS; Midelfort CF; Stinson SF; Boyd MR
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6740-4. PubMed ID: 1713689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
    Romero DL; Busso M; Tan CK; Reusser F; Palmer JR; Poppe SM; Aristoff PA; Downey KM; So AG; Resnick L
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8806-10. PubMed ID: 1717988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.
    Cushman M; Golebiewski WM; McMahon JB; Buckheit RW; Clanton DJ; Weislow O; Haugwitz RD; Bader JP; Graham L; Rice WG
    J Med Chem; 1994 Sep; 37(19):3040-50. PubMed ID: 7932526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human immunodeficiency virus type 1 infectivity by a new amine bellenamine.
    Ikeda R; Haraguchi Y; Ikeda Y; Kondo S; Takeuchi T; Hoshino H
    Antiviral Res; 1996 Mar; 29(2-3):163-73. PubMed ID: 8739596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.
    Prochaska HJ; Yeh Y; Baron P; Polsky B
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3953-7. PubMed ID: 7683414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
    Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
    Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
    Daelemans D; Esté JA; Witvrouw M; Pannecouque C; Jonckheere H; Aquaro S; Perno CF; De Clercq E; Vandamme AM
    Mol Pharmacol; 1997 Dec; 52(6):1157-63. PubMed ID: 9396786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
    Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
    Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
    EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo analysis of castanospermine, a candidate antiretroviral agent.
    Ruprecht RM; Mullaney S; Andersen J; Bronson R
    J Acquir Immune Defic Syndr (1988); 1989; 2(2):149-57. PubMed ID: 2495348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.